Fact-checked by Grok 2 weeks ago

Billroth I

The Billroth I procedure, also known as gastroduodenostomy, is a surgical reconstruction technique performed after distal gastrectomy, in which the distal third of the stomach (antrum) is excised and the remaining gastric pouch is anastomosed directly to the duodenum in an end-to-end or end-to-side fashion to restore gastrointestinal continuity. Developed by Austrian surgeon Theodor Billroth, it represents one of the earliest successful partial gastrectomies in medical history, first performed on January 29, 1881, on a 43-year-old woman with stenosing pyloric carcinoma, involving removal of the pylorus and adjacent stomach tissue under chloroform anesthesia. This procedure is indicated primarily for the treatment of distal gastric cancer, particularly early-stage or well-differentiated tumors amenable to curative resection, as well as benign conditions such as refractory gastric complicated by bleeding, perforation, or obstruction, and recurrent ulcers following eradication. For benign conditions, it is often combined with to reduce acid hypersecretion and ulcer recurrence risk; for malignancy, with dissection. Billroth I preserves physiological food passage and iron absorption pathways. In modern practice, while effective, it is selected when duodenal mobilization (e.g., via Kocher's maneuver) allows tension-free ; Roux-en-Y is preferred in cases prone to . Historically significant for pioneering modern gastric surgery, the Billroth I marked a turning point in the management of gastric pathologies, evolving from open techniques to contemporary laparoscopic and robotic approaches that minimize invasiveness and postoperative complications such as or leakage. Despite its efficacy, long-term outcomes include risks of nutritional deficiencies and due to reduced gastric reservoir capacity, necessitating vigilant postoperative monitoring.

History

Development by Theodor Billroth

Christian Albert was born on April 26, 1829, in , (now part of ), into a family facing economic hardship after his father's early death. He pursued at the universities of , , and , earning his MD degree in 1852 with a thesis on pulmonary . Following postgraduate training in and under prominent figures like Johannes Müller and Bernhard von Langenbeck in , Billroth advanced to become a professor of at the in 1860 before being appointed to the chair of at the in 1867, a position he held until his death on February 6, 1894. At Vienna's Allgemeines Krankenhaus, Billroth established a leading surgical school, emphasizing experimental research and pathological studies to advance operative techniques. He played a key role in adopting antisepsis principles inspired by , implementing strict sterility protocols, including carbolic acid disinfection of instruments and operating rooms, which significantly reduced postoperative infection rates in an era when was rampant. In the , Billroth conducted extensive animal experiments, primarily on dogs, performing numerous procedures to refine suturing techniques for and intestinal while studying digestive and healing. Billroth's conceptual development of partial evolved from recognizing the inadequacies of palliative interventions like , which offered only temporary relief for pyloric obstructions caused by tumors. In discussions and writings around 1880, he proposed excising the diseased pyloric portion of the followed by direct end-to-end gastroduodenal to restore gastrointestinal continuity, a radical shift toward curative intent in gastric . This approach addressed the era's high mortality from and hemorrhage by prioritizing precise, layered suturing to minimize leakage. The 19th-century surgical landscape presented formidable challenges, including uncontrolled infection rates exceeding 50% in abdominal operations due to inadequate sterilization and the limitations of ether or chloroform anesthesia, which often caused respiratory complications without modern monitoring. Billroth overcame these through meticulous operative technique, such as two-layer closures and minimal tissue trauma, honed in his laboratory work, enabling safer resections despite the absence of antibiotics or advanced imaging. His first successful human partial gastrectomy occurred in 1881.

Early Surgical Attempts and First Successes

Following extensive preparatory work on animal models, including partial gastrectomies performed on dogs in 1879, Theodor Billroth proceeded to the first successful human application of the procedure. On January 29, 1881, Billroth conducted the landmark partial gastrectomy at the University Clinic of Surgery in Vienna on a 43-year-old woman named Therese Heller, a mother of eight diagnosed with stenosing pyloric carcinoma. The 1.5-hour operation was performed under chloroform anesthesia, involving resection of the distal stomach and reconstruction via end-to-end gastroduodenostomy, known as the Billroth I anastomosis, using interrupted silk sutures for the mucosal layer and continuous catgut for the seromuscular layer. Heller tolerated the procedure well, resuming semisolid foods within a week and demonstrating adequate gastric function, but she ultimately succumbed to metastatic disease four months postoperatively. This case marked the first documented survival beyond the immediate postoperative period for such an intervention, surpassing prior unsuccessful human attempts, including Jules Péan's 1879 pylorectomy (patient died on postoperative day 5) and Ludwik Rydygier's 1880 procedure (patient died 12 hours postoperatively). Billroth's subsequent cases in 1881 and beyond built on this foundation, with patients showing varying short-term survival before succumbing to disease or complications. Early failures were largely attributable to sepsis and anastomotic leakage, exacerbated by the nascent understanding of antisepsis despite Billroth's adoption of Listerian techniques; infections accounted for the majority of immediate postoperative fatalities. Refinements emerged rapidly to address these challenges, including the adoption of a standardized two-layer anastomosis technique—comprising an inner inverting layer of interrupted silk sutures to approximate the mucosa and an outer continuous layer of catgut for seromuscular reinforcement—which significantly reduced the incidence of leakage compared to single-layer methods. Additionally, experimental work with assistant Anton Wölfler on dogs informed adjustments such as narrowing the gastric lumen to facilitate tension-free approximation during reconstruction. Over time, as operative mortality declined with improved antisepsis and surgical precision, the indication for Billroth I shifted from predominantly oncologic resections for gastric cancer to benign conditions like peptic ulcers and pyloric stenosis, broadening its clinical applicability.

Surgical Procedure

Preoperative Preparation

Preoperative preparation for Billroth I gastrectomy involves a systematic evaluation to confirm surgical candidacy and optimize patient condition, particularly for conditions such as distal gastric adenocarcinoma. Diagnostic assessments begin with upper gastrointestinal endoscopy to visualize the lesion and perform biopsies for histopathological confirmation of malignancy, ensuring the tumor is amenable to curative resection. Complementary imaging, including contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) of the abdomen, is essential to delineate tumor extent, assess lymph node involvement, and evaluate duodenal patency and invasion, which are critical for determining the feasibility of gastroduodenal anastomosis in Billroth I reconstruction. Nutritional status is rigorously assessed through serum albumin levels, prealbumin, and total lymphocyte count to identify malnutrition, which is prevalent in up to 50-80% of gastric cancer patients and correlates with postoperative complications. Patient optimization focuses on addressing modifiable risk factors to enhance against surgical stress. is corrected via iron supplementation or if is below 10 g/dL, while electrolyte imbalances—such as or —are managed through intravenous or oral repletion to stabilize metabolic function. is mitigated with enteral nutritional support, often using jejunal feeding tubes for 7-10 days preoperatively in severely patients ( <18.5 kg/m²), aiming to achieve at least 75% of caloric requirements and improve levels by 0.5-1 g/dL. is mandated at least 4-6 weeks prior to to reduce cardiopulmonary risks, and prophylactic antibiotics, such as , are administered within 60 minutes of incision as per Surgical Care Improvement Project guidelines, though not routinely preoperatively unless is suspected. Anesthesia considerations emphasize safe induction for this major abdominal procedure. General anesthesia with endotracheal is standard, preceded by premedication with anxiolytics like to minimize stress response, and invasive monitoring (, central venous access) is prepared for hemodynamically unstable patients. Preoperative mechanical bowel preparation with solutions may be employed selectively for tumors extending to the distal to facilitate exposure, though evidence supports its omission in most cases to avoid dehydration risks. Risk stratification employs validated tools such as the (ASA) physical status score, where ASA III-IV patients face 2-3 times higher morbidity, or the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (), which predicts 30-day complication rates with an accuracy of 70-80% in gastric surgery cohorts, guiding multidisciplinary discussions on care.

Intraoperative Steps

The intraoperative phase of Billroth I gastrectomy begins with an upper midline incision from the to the umbilicus, providing access to the upper abdomen, or alternatively a chevron incision for enhanced exposure. The abdomen is explored for any metastatic disease in the liver, , omentum, and . Duodenal mobilization is achieved through Kocherization, where the lateral to the is incised and reflected to expose the , facilitating tension-free reconstruction while avoiding injury to the middle colic vessels. The is separated from the , and the is mobilized to access the . Resection involves a distal , removing the and while preserving duodenal integrity. The right gastric and gastroepiploic arteries are divided and ligated to isolate the distal . The is transected 1-2 cm distal to the using a linear stapler or cutter, ensuring a clear margin and avoiding pancreatic . Along the greater curvature, the is divided to mobilize the . The is then transected proximally with a linear cutter, typically resecting the distal two-thirds. In oncologic cases, a D1 or D2 is performed, targeting nodes in stations 1-7 (perigastric) and potentially extending to 8-11 for more advanced disease, with preservation of the short gastric vessels to maintain blood supply to the gastric remnant. Reconstruction follows with an end-to-end gastroduodenostomy to restore gastrointestinal continuity. A Kocher maneuver may be supplemented by Noh's maneuver—incising the gastrohepatic ligament at the fundus to further mobilize the stomach—if tension is anticipated. The anastomosis can be performed hand-sewn in two layers using interrupted absorbable sutures (posterior wall first, then anterior), starting from the lesser curvature side, or with a circular stapler via a modified double-stapling technique through a small gastrotomy, ensuring a tension-free, watertight connection. The staple line on the stomach may be opened toward the greater curvature to align with the duodenal lumen. Closure emphasizes hemostasis throughout, with irrigation of the abdominal cavity to remove debris. A subhepatic drain is placed in the right upper quadrant to monitor for potential leaks or collections. The fascia is closed in layers, followed by skin approximation.

Postoperative Care

Following Billroth I gastrectomy, patients are monitored in an intensive care or step-down unit for vital signs, surgical drain output, and early indicators of anastomotic leak, including tachycardia and fever. A nasogastric tube is routinely placed intraoperatively for gastric decompression and remains in place until return of bowel function, typically within 2 to 3 days postoperatively. Nutritional support begins with nil per os (NPO) status immediately after surgery, advancing to sips of clear liquids on postoperative day 1 or 2, followed by full liquids on day 3 and soft solids by day 4 as gastrointestinal tolerance allows. inhibitors are administered postoperatively to suppress secretion and reduce the risk of marginal ulcers at the gastro-duodenal . Early mobilization is initiated on the day of , with patients encouraged to sit upright for more than 6 hours and ambulate in the evening, progressing to independent activity by postoperative day 1 to enhance and minimize complications. Deep vein thrombosis prophylaxis involves mechanical measures and pharmacological agents such as , starting soon after . Meticulous wound care, including daily inspection and dressing changes, is performed to prevent and promote healing. If is uncomplicated, hospital discharge occurs 5 to 7 days postoperatively, with outpatient follow-up scheduled within 1 to 2 weeks and endoscopic evaluation at approximately 1 month to assess anastomotic integrity.

Indications and Contraindications

Primary Indications

The Billroth I reconstruction is primarily indicated for curative resection of distal gastric , particularly in early to intermediate stages such as T1-T3 tumors confined to the without evidence of duodenal invasion, allowing for subtotal while preserving proximal gastric function. This approach is suitable for tumors located in the or , where complete removal with adequate margins is feasible without compromising duodenal integrity. (NCCN) guidelines recommend subtotal with reconstruction, such as Billroth I, for such localized distal tumors, emphasizing its role in achieving oncologic clearance with minimal disruption to gastrointestinal continuity. For benign gastric pathologies, Billroth I is indicated in cases of refractory peptic ulcers confined to the or that fail medical management, as well as resulting from scarring of healed ulcers. It is also considered for Zollinger-Ellison syndrome when antrectomy is required to control hypersecretion and prevent recurrent ulceration, particularly in patients unsuitable for total or tumor resection alone. These applications stem from the procedure's historical evolution, initially developed for gastric cancer but later adapted for ulcer disease management before the advent of effective acid-suppressive therapies. Billroth I offers advantages in physiological restoration by reestablishing direct gastroduodenal , which promotes more passage and nutrient absorption compared to alternative reconstructions that bypass the . This preservation of the anatomical pathway indirectly supports better postoperative gastric emptying and reduces the risk of certain reflux-related issues, making it the reconstruction of choice when technical feasibility allows.

Contraindications and Patient Selection

The Billroth I reconstruction, involving gastroduodenostomy following distal , is contraindicated in cases of extensive duodenal involvement, such as direct tumor invasion into the , as this precludes safe and increases the risk of leakage or incomplete resection. Similarly, —a diffuse form of gastric —typically requires total due to its extensive intramural spread, rendering partial gastrectomy with Billroth I reconstruction unsuitable. Patients with poor , defined as Eastern Cooperative Oncology Group (ECOG) score greater than 2, face heightened risks and are generally unfit for this major procedure, alongside those deemed unsuitable for general . Advanced necessitating total gastrectomy, such as proximal or multifocal tumors beyond the distal stomach, also represents an absolute contraindication. Relative contraindications include , which can complicate achieving a tension-free due to the fixed and short length of the , potentially leading to anastomotic strain or during . Prior upper abdominal surgeries often result in adhesions that hinder mobilization of the and , increasing operative time and risk, particularly in laparoscopic approaches. Duodenal diameter mismatch, such as narrowing from chronic ulceration or scarring, may impair the creation of a functional end-to-end , further elevating leak risks. Additional relative factors encompass severe comorbidities like cardiopulmonary dysfunction, , , or significant , which compromise healing and overall tolerance. Patient selection for Billroth I prioritizes tumors confined to the distal third of the , allowing adequate margins (typically 4-6 cm proximally) while preserving duodenal passage for physiological benefits. Favorable candidates include younger, fit individuals without extensive comorbidities, as advanced age or diminished may favor less invasive options. Surgeon expertise is crucial, especially for laparoscopic Billroth I, which is preferred over open surgery in select early-stage cases to reduce time and complications, provided no adhesions or anatomical distortions exist. When contraindications arise, alternatives such as or Roux-en-Y reconstruction are considered for improved feasibility, particularly if duodenal mobilization proves inadequate.

Complications and Outcomes

Early Complications

Early complications following Billroth I gastrectomy primarily arise in the immediate postoperative period, within the first 30 days, and are often linked to the technical challenges of the . Anastomotic leak, occurring at an incidence of approximately 2-3%, represents one of the most serious risks, potentially leading to , , and increased mortality if not promptly addressed. Symptoms typically include fever, , , and abnormal drainage from the surgical site, while diagnosis is confirmed via contrast-enhanced studies such as or computed tomography with oral contrast. Management involves initial conservative approaches like nil per os status, broad-spectrum antibiotics, and nutritional support, with reoperation for drainage or repair in severe cases; endoscopic stenting may also be employed to seal minor leaks. Gastric retention due to anastomotic or partial obstruction affects about 3-7% of patients and manifests as persistent , , and delayed oral intake. This condition is managed conservatively with prolonged nasogastric decompression, prokinetic agents, and monitoring until resolution, typically within 7-14 days, avoiding the need for surgical intervention in most instances. Postoperative bleeding, with an incidence of 1-4%, often originates from the suture lines at the and may present as , , or hemodynamic instability. Initial evaluation includes for and via clipping or injection, though is required for uncontrolled hemorrhage. Surgical site , encompassing and superficial infections, occur in 5-10% of cases and are influenced by factors such as operative time and adherence to antisepsis protocols. These are typically managed with care, antibiotics, and if abscess formation occurs, with lower rates observed in laparoscopic approaches compared to open surgery.

Long-Term Outcomes and Risks

Long-term outcomes following Billroth I for gastric cancer demonstrate favorable survival rates, particularly for early-stage distal tumors. For stage II disease, recurrence rates range from 20% to 30% at 5 years, while overall 5-year survival approaches 70% for early distal tumors, reflecting the procedure's efficacy in curative resection when combined with . A common chronic sequela is , affecting 10% to 20% of patients due to rapid gastric emptying into the , with early symptoms occurring within 30 minutes of meals and late hypoglycemic episodes 1 to 3 hours postprandially. Management primarily involves dietary modifications, such as small frequent meals low in simple carbohydrates, which alleviate symptoms in most cases without surgical intervention. Marginal ulcers develop in approximately 5% of patients at the gastro-duodenal anastomosis, attributed to exposure of the duodenal mucosa to hyperacidic gastric contents and potential Helicobacter pylori persistence. The risk of vitamin B12 deficiency is lower with Billroth I reconstruction compared to Billroth II, as the duodenum remains in continuity for intrinsic factor-mediated absorption, with incidence rates around 3% at 4 years post-surgery versus higher rates in bypass procedures. Quality of life post-Billroth I is generally preserved due to its near-physiological food passage, avoiding duodenal bypass-related , with studies indicating better long-term weight maintenance (approximately 10% loss at 5 years) and reduced nutritional deficiencies compared to reconstructions. Randomized trials confirm equivalent or superior status scores versus Roux-en-Y, emphasizing its role in minimizing post-gastrectomy syndrome impacts.

Comparisons with Alternative Reconstructions

Billroth II Gastrectomy

The gastrectomy is a partial procedure that involves resection of the distal , closure of the duodenal stump, and reconstruction via gastrojejunostomy, where the remnant is anastomosed to a loop of proximal brought up in an antecolic or retrocolic fashion. This technique allows for a tension-free and is typically performed using hand-sewn or stapled methods, with variations such as the Polya (using the full stomach lumen) or Hofmeister (posterior wall only) approaches to optimize alignment and reduce complications. Introduced by in 1885 as an alternative to direct gastroduodenostomy when anatomical challenges arise, the procedure is preferred in cases of significant duodenal tension, inflammation, scarring, or when extensive gastric resection shortens the duodenal stump, thereby avoiding the risks of anastomotic leak or ischemia associated with Billroth I reconstruction. It facilitates safer reconstruction in complex scenarios, such as scarred duodenal tissue from prior ulcers, while maintaining gastrointestinal continuity through the jejunal loop. Oncologic outcomes with are comparable to those of Billroth I in patients undergoing distal gastrectomy for gastric cancer. However, the loop configuration predisposes to duodenogastric bile reflux, resulting in alkaline reflux in 20-30% of cases and increased long-term dyspepsia symptoms compared to direct methods. These reflux-related issues arise due to the absence of an anti-reflux mechanism, often manifesting as epigastric pain, , and on , though overall morbidity remains acceptable in appropriately selected patients.

Roux-en-Y Reconstruction

The Roux-en-Y reconstruction is a surgical technique performed following partial (distal) , involving the creation of a Y-shaped configuration from the . In this method, the proximal jejunal limb is anastomosed to the remnant in an end-to-side gastrojejunostomy, while the distal jejunal limb is connected to the or proximal jejunum in a jejunojejunostomy, effectively diverting and pancreatic secretions away from the gastric remnant to prevent their into the . This reconstruction maintains gastrointestinal continuity while minimizing alkaline , a common issue in earlier procedures. Compared to Billroth I reconstruction, Roux-en-Y offers significant advantages in reducing postoperative complications related to . It substantially lowers the incidence of reflux esophagitis and marginal ulcers, primarily by isolating the biliary and pancreatic secretions from the gastroduodenal junction. This anti-reflux mechanism makes it particularly preferable in patients with comorbidities such as or (), where preserving esophageal integrity is crucial. The Roux-en-Y technique gained popularity for distal gastrectomy in the 1970s and 1980s as surgeons sought alternatives to Billroth procedures amid rising reports of reflux-related morbidity. It has since become a standard option for reconstruction after many distal gastrectomies, as outlined in the Japanese Gastric Cancer Association (JGCA) guidelines, which include it among recommended methods alongside and II. Recent advancements as of 2025 include variants such as uncut Roux-en-Y and with Braun , which further reduce bile and improve long-term without compromising oncologic outcomes. These techniques are increasingly adopted in laparoscopic and robotic distal gastrectomies to address complications while preserving functional results. Despite its benefits, Roux-en-Y reconstruction is more technically complex than Billroth I, often requiring longer operative times due to the additional jejunojejunostomy. Potential drawbacks include the risk of internal hernias at mesenteric defects and nutritional deficiencies, such as and iron malabsorption, necessitating long-term monitoring and supplementation.

References

  1. [1]
    Antrectomy (Distal Gastrectomy) - Medscape Reference
    Mar 8, 2023 · A Billroth I procedure is a gastroduodenostomy, which can be fashioned in either an end-to-end or an end-to-side manner.
  2. [2]
    A simple method for tension-free Billroth I anastomosis after ... - NIH
    May 24, 2017 · Billroth I anastomosis (B-I) is a popular reconstructive procedure performed after distal gastrectomy for the treatment of gastric cancer.
  3. [3]
    Theodor Billroth: The Pioneer Gastrectomy Surgeon and His ... - NIH
    Sep 7, 2024 · Billroth entered the history of general surgery with his two famous methods of gastric resection. In his time, the diagnosis of stomach cancer ...
  4. [4]
    [PDF] The Billroth I Gastrectomy - Henry Ford Health Scholarly Commons
    In 1881 Theodor Billroth removed the pyloric seg- ment of the stomach for carcinoma. Gastrointestinal continuity was restored by anastomosing the end of the ...
  5. [5]
    [PDF] Christian Albert Theodor Billroth, M.D., founding father of abdominal ...
    Mar 1, 2012 · Vienna (1867–1894). ... With the aid of his assistants, Billroth refined the technical details of the gastric resection in animals but could not.
  6. [6]
    [PDF] Theodor Billroth (1829-1894) and other protagonists of gastric ...
    He pioneered gastric surgery for cancer. In 1881 he carried out the first successful partial gastrectomy for can- cer. The first pylorectomy was carried out in ...
  7. [7]
    [PDF] Theodor Billroth (1829-1894): pioneer of modern surgery
    Theodor Billroth was born on April 26, 1829 in Prussia to ... He introduced Billroth I in 1881 when he operated on a 43-year-old woman with gastric cancer.
  8. [8]
    Surgery and national identity in late nineteenth-century Vienna - PMC
    During his research, he conducted 28 animal experiments, on dogs, rabbits ... resection of the stomach, operations that were named Billroth I and Billroth II.
  9. [9]
    The First 40 Years of Gastrojejunostomy: From Billroth to ... - NIH
    Sep 1, 2022 · The first successful gastrojejunostomy was reported from Theodor Billroth's Clinic in Vienna. Billroth's clinic was considered to be the most ...
  10. [10]
    (PDF) Theodor Billroth: The Pioneer Gastrectomy Surgeon and His ...
    Sep 15, 2024 · This Historical Review aims to describe the history of a master of surgery such as Billroth, highlighting his attempts to develop gastrectomy ...Missing: 1867 | Show results with:1867
  11. [11]
    Partial Gastrectomy Technique - Medscape Reference
    Feb 21, 2023 · The anastomosis is performed with a continuous absorbable suture that starts from the middle of the posterior layer on either side and is ...
  12. [12]
    Gastric Resection for Malignancy (Gastrectomy) - StatPearls - NCBI
    May 6, 2024 · This is a critical procedure in managing gastric cancer, aiming to remove tumors while preserving healthy tissue and function completely.
  13. [13]
  14. [14]
    Partial gastrectomy and gastrointestinal reconstruction - UpToDate
    Jul 17, 2025 · INTRODUCTION. Partial gastric resection is used to treat cases of benign gastric disease for which resection is indicated; ...
  15. [15]
    Early postoperative imaging after non-bariatric gastric resection
    Jun 19, 2017 · Radical gastrectomy remains a challenging surgical procedure with significant postoperative morbidity (14–43% complication rate) and mortality ( ...Missing: percentage | Show results with:percentage
  16. [16]
    Enhanced recovery after surgery decreases intestinal recovery time ...
    Sep 13, 2018 · Enhanced recovery after surgery (ERAS) reduces postoperative stress, increases patient satisfaction, and reduces postoperative stay and cost ...
  17. [17]
    The safety and feasibility of early postoperative oral nutrition on the ...
    Jun 15, 2013 · Postoperative oral nutrition is safe and feasible on the first postoperative day after gastrectomy. However, elderly patients require careful monitoring.Perioperative Care · Postoperative Outcomes · Discussion
  18. [18]
    Efficacy of Low Dose Proton Pump Inhibitor-Based Therapy to ...
    Nov 10, 2019 · Low-dose PPI-based triple regimen was as effective as standard double-dose PPI-based regimen for H. pylori eradication in patients with subtotal gastrectomy.
  19. [19]
    Inhibiting the proton pump: mechanisms, benefits, harms, and ... - NIH
    Nov 9, 2016 · Proton pump inhibitors are widely used in upper gastrointestinal diseases, including gastric and duodenal ulcers, eradication of Helicobacter pylori in ...
  20. [20]
    Deep venous thrombosis after gastrectomy for gastric carcinoma
    Feb 21, 2009 · Deep venous thrombosis (DVT) is an uncommon complication after gastrectomy for gastric carcinoma. DVT may indicate a worse prognosis.
  21. [21]
    Discharge Instructions for Gastrectomy | Saint Luke's Health System
    Your recovery will take several weeks. · Walk as often as you feel able. · Don't lift anything heavier than 10 pounds until the healthcare provider says it's OK.
  22. [22]
    “Fast track” rehabilitation after gastric cancer resection
    Aug 18, 2014 · Patients' gastrointestinal function was restored rapidly and postoperative hospital stays were reduced to a mean of 5.3 days, compared to other ...
  23. [23]
    Surveillance Endoscopy Guidelines for Postgastrectomy Patients ...
    May 5, 2020 · Routine annual endoscopic follow-up should be performed for up to 20 years after the primary operation for gastric cancer, to allow for early ...
  24. [24]
    Billroth I, a Viable Alternative in Early Distal Gastric Cancers - NIH
    With only one anastomotic site and maintained physiological, intestinal continuity, Billroth I allow an easy postoperative endoscopy, thereby permits access to ...
  25. [25]
    Gastric Cancer - Guidelines Detail - NCCN
    NCCN Guidelines. Firewall Policy · Treatment by Cancer Type · Detection, Prevention, and Risk Reduction · Supportive Care · Specific Populations ...Missing: Billroth reconstruction
  26. [26]
    HEMIGASTRECTOMY, BILLROTH I STAPLED - AccessSurgery
    INDICATIONS. ++. The Billroth I gastric resection along with truncal vagotomy is frequently performed for intractable duodenal ulcer or benign gastric ulcer.
  27. [27]
    Zollinger-Ellison Syndrome - PMC - PubMed Central
    Billroth I or II. Contraindications, Poor medical condition. Patient is a candidate for curative gastrinoma resection. Complications, Gastric outlet obstruction ...Missing: indications benign
  28. [28]
    Part 1???Esophageal, Gastric, and Restrictive Bariatric Procedures
    Billroth I and II reconstructions have historically been used after gastric resection to treat peptic ulcer disease. However, gastric resection is almost never ...Esophageal And Gastric... · Bariatric Surgery · Conclusion
  29. [29]
    CACA guidelines for holistic integrative management of gastric cancer
    Apr 28, 2022 · Reconstruction method for distal gastrectomy: The Billroth I reconstruction is easy to perform and conforms to the physiological approach.
  30. [30]
    Billroth I - an overview | ScienceDirect Topics
    Billroth I is defined as a surgical procedure that involves creating an anastomosis between the duodenum and the gastric remnant, known as gastroduodenostomy.Missing: intraoperative | Show results with:intraoperative
  31. [31]
    Long-term oncologic result of laparoscopic versus open gastrectomy ...
    Apr 7, 2021 · The absolute contraindications to laparoscopic surgery were (1) tumors with direct invasion of the duodenum, pancreatic head, or esophagus; (2) ...Treatment · Outcomes Evaluation · Discussion
  32. [32]
    Surgical Management of Gastric Cancer: A Systematic Review - MDPI
    For patients who have extensive linitis plastica, TG is more frequently performed [26]. ... Although Billroth I was the method of choice for a long time ...
  33. [33]
    Partial Gastrectomy: Background, Indications, Contraindications
    Feb 21, 2023 · In 1881, the Austrian surgeon Theodor Billroth performed a successful gastroduodenostomy in a 43-year-old woman with pyloric cancer. It was ...Missing: 1880 direct
  34. [34]
    Intracorporeal hemi-hand-sewn technique for Billroth-I ...
    Feb 27, 2019 · IC-HHS technique for Billroth-I gastroduodenostomy revealed feasible with acceptable operation time and postoperative outcome.
  35. [35]
    [PDF] Antrectomy and Billroth 1 Gastroduodenostomy Richard Davis ...
    Introduction: Antrectomy and Billroth 1 Gastro- duodenostomy is an excellent operation for gastric outlet obstruction due to healed peptic ulcer disease.
  36. [36]
    Laparoscopy-Assisted Billroth I Gastrectomy Compared With ...
    In our series of Billroth I gastrectomy, operation time of laparoscopic procedure (246 minutes) was not longer than that of conventional technique (228 minutes) ...<|control11|><|separator|>
  37. [37]
    Risk factors and conservative therapy outcomes of anastomotic ...
    Mar 15, 2023 · Anastomotic leakage (AL) after gastrectomy is one of the severest postoperative complications and is related to increasing mortality.
  38. [38]
    Can prospective monitoring improve complication rates after ...
    Jul 13, 2023 · This study aims to review whether prospective monitoring has an effect on postoperative complication rates, especially leakage after Billroth I (BI) ...
  39. [39]
    Treatment and Prevention of Postoperative Leakage after ... - MDPI
    It is recommended that surgical treatment be attempted first for anastomotic leakage of gastrojejunostomy site and gastric stump in remnant stomach.
  40. [40]
    Assessment of risk factors for delayed gastric emptying after distal ...
    Sep 23, 2022 · Delayed gastric emptying (DGE) represents one of the major ... The surgical procedures included Billroth I, Billroth II, or RY ...
  41. [41]
  42. [42]
    Endoscopic treatment and risk factors of postoperative anastomotic ...
    The bleeding sites were as follows: Billroth-I anastomosis using a circular ... postoperative anastomotic bleeding had an incidence ranging from 0.6 to 4.4%.
  43. [43]
    Endoscopic management of postoperative bleeding - PMC - NIH
    Nov 2, 2023 · ... bleeding three weeks after the creation of Billroth I anastomosis.55 ... 69 The incidence of postoperative bleeding was more frequent ...
  44. [44]
    Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?
    Dec 9, 2009 · Billroth II method of anastomosis was associated with higher rate of early postoperative complications. Therefore, we conclude that the Billroth I method ...
  45. [45]
    Overweight is a risk factor for surgical site infection following distal ...
    Jul 11, 2012 · All 355 patients, 174 with Billroth-I reconstruction, 165 with Roux ... Identifying patients at high risk of surgical wound infection.
  46. [46]
    Survival outcomes in patients with stages I–III gastric ... - POL Scientific
    Prognosis varies with stage (I–IV), with stages I–III showing promising 5-year survival rates up to 71.8%, warranting timely diagnosis and treatment. Surgery is ...
  47. [47]
    Life expectancy of patients with early gastric cancer who underwent ...
    Feb 12, 2025 · The survival rate for stage 1 gastric cancer is notably better, with reported 5-year survival rates of about 94.4% for stage IA and 84.2% for ...
  48. [48]
    Dumping Syndrome - StatPearls - NCBI Bookshelf - NIH
    In patients who have undergone gastric surgery, an estimated 20% to 50% of patients have symptoms of Dumping syndrome. Patients develop severe symptoms ...
  49. [49]
    Dumping Syndrome: Background, Pathophysiology, Etiology
    Oct 11, 2025 · The incidence of significant dumping has been reported to be 6-14% in patients after truncal vagotomy and drainage and from 14-20% after partial ...Background · Pathophysiology · Etiology
  50. [50]
    Giant marginal ulcer - PubMed
    Marginal ulcer is a well-known complication of gastroenterostomy. It occurs in 3% of patients post-Billroth II subtotal gastrectomy; it occurs in less than ...Missing: rate | Show results with:rate
  51. [51]
    Incidence and clinical features of endoscopic ulcers developing after ...
    Jul 7, 2012 · The incidence of endoscopic ulcers after gastrectomy was 9.3% and that of marginal ulcers was 8.6%. Ulcers were more common in patients with Billroth II ...
  52. [52]
    Methylmalonic Acid and Homocysteine as Indicators of Vitamin B12 ...
    Feb 21, 2019 · Lim et al. reported that at 48 months after gastrectomy, the incidence of vitamin B12 deficiency was 3.2% in patients that had a Billroth I ...
  53. [53]
    Comparison of 5‐year postoperative outcomes after Billroth I and ...
    Sep 15, 2020 · Body weight loss 5 years after surgery did not differ significantly between the Billroth I and Roux-en-Y groups (10.0% ± 7.9% and 9.6% ± 8.4%, ...
  54. [54]
    Randomized clinical trial comparing long-term quality of ... - PubMed
    Conclusion: The choice of anastomotic reconstruction after distal gastrectomy resulted in no difference in long-term QoL in patients with gastric cancer.
  55. [55]
    Comparison of quality of life between Billroth-І and Roux-en-Y ...
    Sep 12, 2017 · The aim of this trial was to compare the quality of life (QoL) of BI with RY reconstruction after curative distal gastrectomy for gastric cancer.Missing: sepsis | Show results with:sepsis
  56. [56]
    A primer to common major gastrointestinal post-surgical anatomy on ...
    Billroth 1 and 2. These surgeries are indicated for gastric malignancy and refractory peptic ulcer disease. Billroth 1 surgery entails a partial gastrectomy ( ...
  57. [57]
    Review Reconstruction after gastrectomy: Which technique is best?
    In any case, Billroth II seems better than Billroth I in terms of postoperative morbidity and does not compromise carcinologic margins. Reconstruction ...
  58. [58]
    Antrectomy - Basicmedical Key
    Feb 6, 2017 · A Billroth I procedure cannot always be performed due to inflammation and scarring from prepyloric, pyloric, or duodenal ulcers. In these ...Missing: inflamed scarred
  59. [59]
    Optimal reconstruction methods after distal gastrectomy for gastric ...
    Roux-en-Y reconstruction is superior to Billroth I and Billroth II reconstruction in terms of preventing bile reflux and remnant gastritis.
  60. [60]
    Long-term Functional and Patient-reported Outcomes Between Intra ...
    In a recent meta-analysis, eight randomized controlled trials comparing outcomes between Billroth I, Billroth II, and Roux-en-Y anastomosis were analyzed [20].Surgical Outcomes In Psm... · Endoscopic Findings In Psm... · Qol In Psm PatientsMissing: indications | Show results with:indications
  61. [61]
    Roux‐en‐Y versus Billroth‐I reconstruction after distal gastrectomy ...
    Billroth‐I reconstruction may shorten postoperative hospital stay, but the evidence for this outcome is very uncertain (MD 0.96, 95% CI 0.16 to 1.76; I² = 56%; ...
  62. [62]
    Roux-en-Y versus Billroth-I reconstruction after surgery for gastric ...
    Sep 15, 2021 · Roux-en-Y reconstruction probably reduces the incidence of bile reflux into the remnant stomach compared to Billroth-I reconstruction. Billroth- ...
  63. [63]
    The advantages and disadvantages of a Roux-en-Y reconstruction ...
    The advantages of Roux-en-Y reconstruction after a distal gastrectomy include a reduction of reflux gastritis and esophagitis, a decreased probability of ...
  64. [64]
    Roux-en-Y versus Billroth I reconstruction after distal gastrectomy for ...
    For several decades, R-Y reconstruction has been the preferred method to prevent reflux gastritis, esophagitis and decrease probability of gastric cancer ...
  65. [65]
    History of gastric cancer surgery - ResearchGate
    Aug 5, 2025 · Both Billroth I (B-I) and Roux-en-Y (R-Y) anastomoses have been performed as standard procedures after distal gastrectomy [1] . B-I was once ...
  66. [66]
    Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)
    The standard surgical procedure for clinically node-positive (cN +) or T2–T4a tumors is either total or distal gastrectomy. Distal gastrectomy is selected when ...
  67. [67]
    A Novel Roux-en-Y Reconstruction Involving the Use of Two ...
    Sep 26, 2017 · Distal subtotal gastrectomy and proper lymphadenectomy are common surgical strategies used for treatment of gastric cancer affecting the middle ...<|control11|><|separator|>
  68. [68]
    Roux-en-Y Gastric Bypass - StatPearls - NCBI Bookshelf
    Roux-en-Y gastric bypass (RYGB) is a surgical procedure for weight loss that involves creating a stomach pouch and rerouting the small intestine to this pouch.Roux-En-Y Gastric Bypass · Anatomy And Physiology · Complications<|control11|><|separator|>